Results 21 to 30 of about 16,990 (173)

Serological association of Chlamydia pneumoniae infection with age-related macular degeneration: a systematic review and meta-analysis.

PLoS ONE, 2014
BackgroundWe investigated the serological association of Chlamydia pneumoniae infection with age-related macular degeneration (AMD).MethodsA systematic review and meta-analysis was performed. PubMed, Embase, Web of Science and the Association of Research
Xueyu Chen, Vishal Jhanji, Chupeng Chen, Haoyu Chen   +3 more
doaj   +1 more source

Chlamydia pneumoniae in atherosclerosis [PDF]

Atherosclerosis, 1999
Abstract. Saikku P (National Public Health Institute, Oulu, Finland). Chlamydia pneumoniae in atherosclerosis (Minisymposium). J Intern Med 2000; 247: 391–396. Chlamydia pneumoniae is currently the infectious agent most often associated with the inflammation found in atherosclerosis.
openaire   +2 more sources

Astrocytes infected with Chlamydia pneumoniae demonstrate altered expression and activity of secretases involved in the generation of β-amyloid found in Alzheimer disease

BMC Neuroscience, 2019
Background Epidemiologic studies strongly suggest that the pathophysiology of late-onset Alzheimer disease (AD) versus early-onset AD has environmental rather than genetic causes, thus revealing potentially novel therapeutic targets to limit disease ...
Zein Al-Atrache, Danielle B. Lopez, Susan T. Hingley, Denah M. Appelt   +3 more
doaj   +1 more source

Frequency of Mycoplasma pneumoniae, Legionella pneumophila and Chlamydia spp. among patients with atypical pneumonia in Tehran

New Microbes and New Infections, 2020
Mycoplasma pneumoniae, Legionella pneumophila and Chlamydia pneumoniae are the most common bacterial agents, which account for 15–40%, 2–15% and 5–10% of atypical community-acquired pneumonia (CAP) respectively.
N. Noori Goodarzi, M.R. Pourmand, M. Rajabpour, M. Arfaatabar, M. Mosadegh, S.A. Syed Mohamad   +5 more
doaj   +1 more source

Reactive Infectious Mucosal Eruptions (RIME) Secondary to Chlamydia pneumoniae Infection

Reports, 2021
Reactive infectious mucosal eruptions (RIME) following Chlamydia pneumoniae infection is a rare and poorly understood clinical presentation that can pose a diagnostic challenge.
Frederik Færgemann Lau, Andreas Ronit, Nina Weis, Anni Winckelmann   +3 more
doaj   +1 more source

Is there a Relation between Chlamydia Infection and Primary Biliary Cirrhosis?

Clinical and Developmental Immunology, 2003
Over the past two decades, a number of studies have failed to provide direct evidence of specific microbial chronic infection in primary biliary cirrhosis (PBC).
Patrick S. C. Leung, Ogyi Park, Shuji Matsumura, Aftab A. Ansari, Ross L. Coppel, M. Eric Gershwin   +5 more
doaj   +1 more source

Mycoplasma pneumoniae and Chlamydia spp. Infection in Community-Acquired Pneumonia, Germany, 2011–2012

Emerging Infectious Diseases, 2015
Mycoplasma pneumoniae and Chlamydia spp., which are associated with community-acquired pneumonia (CAP), are difficult to propagate, and can cause clinically indistinguishable disease patterns.
Roger Dumke, Christiane Schnee, Mathias W. Pletz, Jan Rupp, Enno Jacobs, Konrad Sachse, Gernot Rohde, CAPNETZ Study Group   +7 more
doaj   +1 more source

Chronic infection with Chlamydia pneumoniae in asthma: a type-2 low infection related phenotype

Respiratory Research, 2021
Background Chlamydia pneumoniae and Mycoplasma pneumoniae have been implicated in the pathogenesis of asthma and are responsible for chronic inflammation when host immune system fails to eradicate the bacteria.
Doriane Calmes, Pascale Huynen, Virginie Paulus, Monique Henket, Françoise Guissard, Catherine Moermans, Renaud Louis, Florence Schleich   +7 more
doaj   +1 more source

Chlamydia pneumoniae and asthma [PDF]

Thorax, 1998
This study was designed to test the association of Chlamydia pneumoniae infection with asthma in a multi-racial population, after adjustments for several potential confounding variables.Antibodies to C pneumoniae were measured by microimmunofluorescence in 123 patients with acute asthma, 1518 control subjects admitted to the same hospital with various ...
P J, Cook, P, Davies, W, Tunnicliffe, J G, Ayres, D, Honeybourne, R, Wise   +5 more
openaire   +5 more sources

Pharmacokinetics of dolutegravir, tenofovir and lamivudine during venous–venous extracorporeal membrane oxygenation (VV‐ECMO): A case report

British Journal of Clinical Pharmacology, EarlyView.
While providing potentially life‐saving cardiorespiratory support for critically ill patients, extracorporeal membrane oxygenation (ECMO) may detrimentally affect pharmacokinetic (PK) performance and concurrent drug efficacy and safety. We describe a patient with Pneumocystis jirovecii pneumonia (PJP) in the context of acquired immunodeficiency ...
Tom C. Zwart, Emiel Leegwater, Thomas H. Ottens, Emile F. Schippers, Erik B. Wilms, David M. Burger, Cees van Nieuwkoop, Liesbeth B. E. Bosma   +7 more
wiley   +1 more source